Introduction: Placental development is a highly regulated process that begins with the implantation of the blastocyst into the uterine wall and culminates in the formation of a fully functional placenta by the end of the first trimester. Objectives: The main objective of the study is to find the implications of placental insufficiency on fetal organogenesis and long-term health outcomes. Methodology: This prospective observational study was conducted at various tertiary care hospitals in KSA during June 2023 to March 2024. Data were collected from 118 pregnant women. Data collection included both maternal and fetal information, acquired through routine antenatal visits and detailed assessments during delivery. Maternal data encompassed a range of factors, such as age, medical history, and any pregnancy-related complications. Results: Data were collected from 118 patients. Mothers with mild insufficiency had a mean age of 28.5 ± 3.5 years, while those with severe insufficiency were slightly older at 30.2 ± 4.0 years. The gestational age at diagnosis decreased with the severity of insufficiency, with mild insufficiency diagnosed at 29.5 ± 2.1 weeks compared to 26.8 ± 2.0 weeks for severe cases. In the mild insufficiency group, only 5% of children exhibited developmental delays, with no reported cases of elevated blood pressure or metabolic syndrome by age 3. Conclusion: It is concluded that placental insufficiency significantly impacts fetal growth, organ development, and long-term health outcomes. As placental dysfunction increases, the risk of intrauterine growth restriction (IUGR) rises, leading to complications such as preterm birth, low birth weight, and a higher likelihood of requiring neonatal intensive care